Clinical trial
Concurrent Chemo-radiotherapy With IMRT for Stage I-III Small Cell Lung Cancer
NCT01166191 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concurrent Chemo-radiotherapy With IMRT for Stage I-III Small Cell Lung Cancer
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- May 31, 2017
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stage i-iii small cell lung cancer